Anna Finley Caulfield, MD

Clinical Professor, Neurology & Neurological Sciences

Clinical Focus

Neurology
Neurocritical Care
Vascular Neurology

Academic Appointments

Clinical Professor, Neurology & Neurological Sciences

Administrative Appointments

Fellowship Director, Neurocritical Care, Stanford Department of Neurology (2013 - Present)

Professional Education

Board Certification: American Board of Psychiatry and Neurology, Neurocritical Care (2021)
Bachelor of Science, College of William & Mary, Biology (1994)
Medical Education: Georgetown University School of Medicine (1999) DC
Internship: Medstar Georgetown University Hospital Internal Medicine Residency (2000) DC
Residency: UCLA Dept of Neurology (2003) CA
Fellowship: Beth Israel Deaconess Vascular Neurology Fellowship (2004) MA
Fellowship, Stanford University Medical Center, Neurocritical Care (2006)
Board Certification, Neurology, American Board of Psychiatry and Neurology (2004)
Board Certification: American Board of Psychiatry and Neurology, Vascular Neurology (2008)
Board Certification, American Board of Psychiatry and Neurology, Neurocritical Care (2021)

Contact

Administrative Contact Valerie Berland Administrative Associate vberland@stanford.edu Tel: 650-723-2606

Clinical Neuroscience Clinic 300 Pasteur Dr A301 Boswell Bldg MC 5327 Stanford CA 94305 Tel: (650) 723-6469 Fax: (650) 725-0390

Current Research and Scholarly Interests

Dr. Finley joined the Stanford Stroke Center in 2004 from Beth Israel Deaconess Medical Center in Boston. She cares for acute stroke patients and other neurologically critical ill patients in the intensive care unit. Currently, her research interests include hypothermia after cardiac arrest and comparing health care provider's predications of future neurological function in neurologically critical ill patients to their 6-month outcome.

Clinical Trials

Insulin Resistance Intervention After Stroke Trial Not Recruiting
More
The purpose of this study is to determine if pioglitazone is effective in preventing future strokes or heart attacks among non-diabetic persons who have had a recent ischemic stroke.

Stanford is currently not accepting patients for this trial. For more information, please contact Madelleine Garcia, 6507252326.
Lead Sponsor
Stanford Investigators
View full details
Progesterone for the Treatment of Traumatic Brain Injury III Not Recruiting
More
The ProTECT study will determine if intravenous (IV) progesterone (started within 4 hours of injury and given for a total of 96 hours), is more effective than placebo for treating victims of moderate to severe acute traumatic brain injury.

Stanford is currently not accepting patients for this trial. For more information, please contact Rosen Mann, 6507212645.
Lead Sponsor
Stanford Investigators
View full details
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4) Not Recruiting
More
The purpose of the study is to determine whether desmoteplase is effective and safe in the treatment of patients with acute ischaemic stroke when given within 3 to 9 hours from onset of stroke symptoms.

Stanford is currently not accepting patients for this trial. For more information, please contact Maarten Lansberg, 6507234448.
Lead Sponsor
Stanford Investigators
View full details
Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk Not Recruiting
More
Transient ischemic attack (TIA) is a transient neurological deficit (speech disturbance, weakness…), caused by temporary occlusion of a brain vessel by a blood clot that leaves no lasting effect. TIA diagnosis can be challenging and an expert stroke evaluation combined with magnetic resonance imaging (MRI) could improve the diagnosis accuracy. The risk of a debilitating stroke can be as high as 5% during the first 72 hrs after TIA. TIA characteristics (duration, type of symptoms, age of the patient), the presence of a significant narrowing of the neck vessels responsible for the patient's symptoms (symptomatic stenosis), and an abnormal MRI are associated with an increased risk of stroke. An emergent evaluation and treatment of TIA patients by a stroke specialist could reduce the risk of stroke to 2%. Stanford has implemented an expedited triage pathway for TIA patients combining a clinical evaluation by a stroke neurologist, an acute MRI of the brain and the vessels and a sampling of biomarkers (Lp-PLA2). The investigators are investigating the yield of this unique approach to improve TIA diagnosis, prognosis and secondary stroke prevention. The objective of this prospective cohort study is to determine which factors will help the physician to confirm the diagnosis of TIA and to define the risk of stroke after a TIA.

Stanford is currently not accepting patients for this trial. For more information, please contact Stephanie Kemp, BS, 650-723-4481.

Lead Sponsor
- Stanford University
Stanford Investigators
View full details
Computed Tomography Perfusion (CTP) to Predict Response to Recanalization in Ischemic Stroke Project (CRISP) Not Recruiting
More
The overall goal of the CTP to predict Response to recanalization in Ischemic Stroke Project (CRISP) is to develop a practical tool to identify acute stroke patients who are likely to benefit from endovascular therapy. The project has two main parts. During the first part, the investigators propose to develop a fully automated system (RAPID) for processing of CT Perfusion (CTP) images that will generate brain maps of the ischemic core and penumbra. There will be no patient enrollment in part one of this project. During the second part, the investigators aim to demonstrate that physicians in the emergency setting, with the aid of a fully automated CTP analysis program (RAPID), can accurately predict response to recanalization in stroke patients undergoing revascularization. To achieve this aim the investigators will conduct a prospective cohort study of 240 consecutive stroke patients who will undergo a CTP scan prior to endovascular therapy. The study will be conducted at four sites (Stanford University, St Luke's Hospital, University of Pittsburgh Medical Center, and Emory University/Grady Hospital). Patients will have an early follow-up MRI scan within 12+/-6 hours to assess reperfusion and a late follow-up MRI scan at day 5 to determine the final infarct.

Stanford is currently not accepting patients for this trial. For more information, please contact Stephanie M Kemp, BS, 650-723-4481.

Lead Sponsor
- Stanford University
Stanford Investigators
View full details
Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3) Not Recruiting
More
The purpose of this pivotal study is to demonstrate safety and efficacy of transcranial laser therapy (TLT) with the NeuroThera® Laser System in the treatment of subjects diagnosed with acute ischemic stroke. The initiation of the TLT procedure must be feasible for each subject between 4.5 and 24 hours of stroke onset.

Stanford is currently not accepting patients for this trial. For more information, please contact Stephanie Kemp, 6507234481.
Lead Sponsor
Stanford Investigators
View full details
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III Recruiting
More
The overall objective of this Phase III clinical trial is to obtain information from a population of 500 ICH subjects with intraventricular hemorrhage (IVH), representative of current clinical practice and national demographics of ICH regarding the benefit (or lack thereof) of IVH clot removal on subject function as measured by modified Rankin Scale (mRS). This application requests funding for five years to initiate a Phase III randomized clinical trial (RCT) testing the benefit of clot removal for intraventricular hemorrhage. The investigators propose to compare extraventricular drainage (EVD) use plus recombinant tissue plasminogen activator (rt-PA; Alteplase; Genentech, Inc., San Francisco, CA) with EVD+ placebo in the management and treatment of subjects with small intracerebral hemorrhage (ICH) and large intraventricular hemorrhage (IVH defined as ICH < 30 cc and obstruction of the 3rd or 4th ventricles by intraventricular blood clot).
Lead Sponsor
Stanford Investigators
View full details
Diagnostic Utility of MRI in Intracerebral Hemorrhage Not Recruiting
More
The overall aim of this project is to prospectively determine whether MRI can improve the conventional neuroradiological evaluation (CT with or without cerebral angiography) of patients with a spontaneous ICH or IVH. The study design will also allow us to identify the added benefit of specific MR sequences and repeat MRI in the chronic stage, thereby allowing us to prospectively determine their value in a consecutive series of patients. This information should have a major impact on the management of these patients by providing data on the diagnostic yield of routine MRI in patients presenting with a wide variety of causes for ICH or IVH. These data will help guide the diagnostic evaluation and the management of brain hemorrhage patients in the future.

Stanford is currently not accepting patients for this trial. For more information, please contact Stephanie M Kemp, BS, 650-723-4481.

Lead Sponsor
- Stanford University
Stanford Investigators
View full details

2023-24 Courses

Independent Studies
- Directed Reading in Neurology and Neurological Science
  NENS 299 (Aut, Win, Spr, Sum)
- Early Clinical Experience in Neurology and Neurological Sciences
  NENS 280 (Aut, Win, Spr, Sum)
- Graduate Research
  NENS 399 (Aut, Win, Spr, Sum)
- Medical Scholars Research
  NENS 370 (Aut, Win, Spr, Sum)
- Undergraduate Research
  NENS 199 (Aut, Win, Spr, Sum)

All Publications

Profiles With Related Publications

close
Gregory W. Albers, MD

Coyote Foundation Professor and Professor, by courtesy, of Neurosurgery
Clinical Focus
Neurology
Research Interests
Our group's research focus is the acute treatment and prevention of cerebrovascular disorders. Our primary interest is the use of advanced imaging techniques to expand the treatment window for ischemic stroke. We are also conducting clinical studies of both neuroprotective and thrombolytic strategies for the treatment of acute stroke and investigating new antithrombotic strategies for stroke prevention.

667 Total Publications
close
Patrick Barnes

Professor of Radiology (Pediatric Radiology) at the Stanford University Medical Center, Emeritus
Research Interests
Advanced imaging, including magnetic resonance imaging, of injury to the developing central nervous system; including fetal, neonatal, infant and young child; and, including nonaccidental injury (e.g. child abuse).

See Biosketch for details.

193 Total Publications
close
Hansen Chen

Postdoctoral Scholar, Neurosurgery

34 Total Publications
close
Bernard Dannenberg

Clinical Professor, Emergency Medicine Clinical Professor, Pediatrics
Clinical Focus
Pediatric Emergency Medicine
Research Interests
Pediatric Pain Management and Sedation

8 Total Publications
close
Nancy Fischbein

Professor of Radiology and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) , of Neurology, of Neurosurgery & of Radiation Oncology
Clinical Focus
Neuroradiology

210 Total Publications
close
Prasanthi Govindarajan

Associate Professor of Emergency Medicine
Clinical Focus
Emergency Medicine, Stroke, Emergency Medical Services, Health Services Research, Neurologic emergencies
Research Interests
My current research focuses on using large databases to understand the effect of state or county-wide public policy on health care outcomes (specifically stroke). Our team is also exploring how patient safety, effective and equitable care in acute stroke management can be achieved using technology.

40 Total Publications
close
Karen G. Hirsch, MD

Associate Professor of Neurology and, by courtesy, of Neurosurgery
Clinical Focus
Neurology, Stroke, Traumatic Brain Injury, Cardiac Arrest, Coma, Brain Death, Hypoxic ischemic Brain Injury

66 Total Publications
close
Andre Kumar MD, MEd

Clinical Associate Professor, Medicine
Clinical Focus
Internal Medicine, Hospital Medicine

33 Total Publications
close
Michael Ma

Assistant Professor of Cardiothoracic Surgery (Pediatric Cardiac Surgery)
Clinical Focus
Neonatal Cardiac Surgery, Pediatric Cardiac Surgery, Thoracic and Cardiovascular Surgery
Research Interests
Our lab aims to understand the biomechanics that govern a wide spectrum of congenital heart defects, and how those biomechanics change with contemporary operative repair strategies. We simulate operations virtually via CFD, and in ex vivo and in vivo animal models, and analyze how the changes we make alter fluid flow, pressure, and stresses throughout the system. We hope that these experiments can impact and optimize existing techniques that translate quickly to the operating room.

101 Total Publications
close
Michael P. Marks, MD

Professor of Radiology (General Radiology), Emeritus
Clinical Focus
Interventional Neuroradiology, Cerebrovascular Disorders, Stroke Treatment and Imaging, Brain Aneurysms, Arteriovenous Malformations, Diagnostic Radiology
Research Interests
Interventional neuroradiology; cerebral arteriovenous malformations; stroke treatment and imaging; cerebral aneurysms

340 Total Publications
close
Christina Mijalski Sells

Clinical Associate Professor, Neurology & Neurological Sciences
Clinical Focus
Neurology

8 Total Publications
close
Tsuyoshi (Yoshi) Mitarai

Clinical Associate Professor, Emergency Medicine
Clinical Focus
Emergency Critical Care, Internal medicine/critical care medicine, High risk pulmonary embolism, Providing delayed comfort care in Clinical Decision Units (CDU) for ED patients with life support, Critical Care Medicine
Research Interests
Critical Care, optimal resource allocations for inpatient care

13 Total Publications